Sienna Biopharmaceuticals Stock (OTC: SNNAQ)

Latest news for Sienna Biopharmaceuticals (OTC:SNNAQ) Stock

Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.

News

Intraday Update

Markets

Movers

Trading Ideas

ABEV

ABIO

ABMD

ABVC

ACCYY

ACHV

ACIW

ACOR

ACRFF

ACRX

ACSAY

ACST

ADHC

ADMA

ADMP

AEGOF

AFLYY

AFRAF

AGCO

AGEEF

AHKSY

AHOTF

AIBGY

AIPUY

AKRX

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALLY

ALMFF

ALOT

ALSN

ALTM

ALXN

AMADY

AMCX

AMKBF

AMKBY

AMNP

AMPH

AMRH

AMRQQ

AMTX

ANAT

ANCN

ANGO

ANIP

ANZLY

APEX

APHA

APLE

APTS

AQARF

ARCB

ARCH

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARTL

ASNA

ASTVF

ATRA

ATRI

ATROB

ATSG

ATUSF

AUTL

Stocks That Hit 52-Week Lows On Thursday

Movers & Shakers

General

AMIH

APRN

BCCMY

BNXR

BTKGF

CBDEF

CEIX

CGEI

CIMEF

CMGHY

COFE

CONN

CORX

CTXDF

DCTHD

DLPH

DLRYF

DRTT

ENTA

FQVTF

FRBK

GBPT

GPOR

GTLL

HGSH

HNRG

HPYCF

HWKE

IDLM

IMTO

JBZY

JRNGF

KEQU

KGET

KONAQ

LFCOF

LKCO

MCUJF

MICFF

MMJJF

NABIF

NAKD

NMGC

NVGI

OLLI

PPJE

PRTT

RNLSY

SEEK

SMTTF

SYNNF

TAST

TVOG

UIHC

VBIX

VISIUM TECHNOLOGIES INC by Visium Technologies, Inc.

VISM

WDHR

WKRCF

YGYI

CFEIY

SNNAQ

Stocks That Hit 52-Week Lows On Tuesday

AONCF

APTY

ARGQ

ARST

BDCO

BDRAF

BDRBF

CHYHY

CNTMF

COWI

FLDPF

FUTL

GARB

GOTRF

GWRRF

HESG

HLFDF

IMBI

INND

LIXT

MINE

ORAN

ORVRF

SGRWF

SVSN

TBEV

TGRO

UAMA

ALIZY

SIENNA BIOPHARMACEUTICALS by Sienna Biopharmaceuticals, Inc.

Sienna Biopharmaceuticals Inc

Janus International Launches Two New Roll-Up NS Series Self-Storage Door Solutions

Jiyue, the electric vehicle (EV) manufacturer formed by Baidu, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) in collaboration with Geely Holding Group, is set to introduce its latest model, the <a target="_blank" href="https://www.benzinga.com/electric-vehicles" rel="noreferrer noopener">Jiyue 07 electric sedan, in September.</a>
The Jiyue 07, which follows the Jiyue 01 SUV as the second model under the Jiyue brand, is already on display at certain Jiyue showrooms, <a target="_blank" href="https://cnevpost.com/2024/07/16/jiyue-to-launch-jiyue-07-sept/" rel="noreferrer noopener">reported</a> CnEV Post.
The dimensions of the Jiyue 07 exceed those of Tesla&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Model 3.
The Model 3 measures 4,724 mm in length, 1,848 mm in width, and 1,430 mm in height, with a wheelbase of 2,875 mm. Comparatively, the Jiyue 07 measures 4,953 mm in length, 1,989 mm in width, and 1,475 mm in height, with a wheelbase of 3,013 mm.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39749573/nio-advances-vehicle-safety-with-ai-enhanced-automatic-emergency-braking-and-navigation-features" rel="noreferrer noopener">NIO Advances Vehicle Safety With AI-Enhanced Automatic Emergency Braking And Navigation Features In Latest Update</a>
According to a regulatory filing on May 11, the Jiyue 07 will be manufactured at Geely&#8217;s plant in Ningbo, Zhejiang province. It will be available in both single-motor and dual-motor configurations.
The single-motor version features an electric motor capable of delivering up to 200 kW of power, while the dual-motor version includes an additional front motor also capable of 200 kW, both supplied by Geely Auto&#8217;s affiliate Viridi E-mobility Technology.
The Jiyue 07 offers two choices of battery packs: 71.4 kWh and 100 kWh, sourced from suppliers such as CATL and Svolt Energy. It boasts a range of up to 880 kilometers on a single charge, with intermediate options of 660 kilometers and 770 kilometers, the report highlighted.
Originally named Jidu, the brand underwent a renaming to Jiyue after Geely and Baidu formed the joint venture in March 2021. Initially, Baidu held a 55% stake while Geely owned 45%. On August 15, 2023, Geely announced the rebranding to Jiyue, replacing Jidu, potentially due to regulatory considerations.
Jiyue unveiled the Jiyue 07 sedan for the first time at the Beijing Auto Show in late April 2024.
Price Action: BIDU shares are trading lower by 0.32% to $92.85 premarket at last check Tuesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo by testing on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39755144/airbus-launches-lead-initiative-reportedly-aims-to-strengthen-aircraft-manufacturing-ahead-of-bo" target="_blank" rel="noreferrer noopener">Airbus Launches &#8216;LEAD!&#8217; Initiative, Reportedly Aims To Strengthen Aircraft Manufacturing Ahead Of Boeing&#8217;s Recovery</a></li>
</ul>

Equities

Media

BIDU

TSLA

Baidu-Backed Jiyue To Launch Jiyue 07 Electric Sedan In September; Larger Than Tesla Model 3: Report

Wolfe Research analyst Shweta Khajuria assumes Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Peer Perform rating.

Initiation

Analyst Ratings

RBLX

Wolfe Research Assumes Roblox at Peer Perform

Earnings

PNC Financial Services Q2 Net Interest Income Decreases To $3.302B Compared With $3.510B YoY; Q2 Noninterest Income Totals $2.109B Higher Than $1.783B YoY

Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) is scheduled to release its financial results for the second quarter, before the <a href="https://www.benzinga.com/quote/MS/earnings">opening bell on Tuesday, July 16.</a>
Analysts expect the New York-based company to report quarterly earnings at $1.65 per share, up from $1.24 per share in the year-ago period. Morgan Stanley expects to post revenue of $14.3 billion. It posted $13.08 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Morgan Stanley is set to launch an AI-powered assistant to enhance the workflow of its financial advisors. The AI assistant, named Debrief, will automate the note-taking process during client meetings, creating draft emails and summaries of the discussions, CNBC reported recently.
Morgan Stanley shares gained 1.1% to close at $105.26 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/MS/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Oppenheimer analyst Chris Kotowski maintained an Outperform rating and raised the price target from $101 to $105 on April 30. This analyst has an accuracy rate of 84%.</li>
<li>BMO Capital analyst James Fotheringham maintained an Outperform rating and boosted the price target from $115 to $118 on April 18. This analyst has an accuracy rate of 73%.</li>
<li>B of A Securities analyst Michael Carrier maintained a Buy rating and increased the price target from $100 to $106 on April 17. This analyst has an accuracy rate of 80%.</li>
<li>Keefe, Bruyette &amp; Woods analyst David Konrad maintained a Market Perform rating and raised the price target from $94 to $98 on April 17. This analyst has an accuracy rate of 75%.</li>
<li>CFRA analyst Kenneth Leon maintained a Buy rating and increased the price target from $97 to $108 on April 16. This analyst has an accuracy rate of 77%.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39770776/over-18m-bet-on-this-tech-stock-check-out-these-4-stocks-insiders-are-buying">Over $18M Bet On This Tech Stock? Check Out These 4 Stocks Insiders Are Buying</a></li>
</ul>

Price Target

Pre-Market Outlook

Morgan Stanley Likely To Report Higher Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Earnings Beats

CORRECTION: Bank of America Q2 2024 GAAP EPS $0.83 Beats $0.80 Estimate, Sales $25.537B Beat $25.220B Estimate

Dividends

Bank of America Announced Plans For An 8% Increase In Quarterly Common Stock Dividend, To $0.26 Per Share, Pending Board Approval

Bank of America Q2 Consumer Banking Revenue $10.2B, Down 3%; Sales And Trading Revenue Up 9%, Total Investment Banking Fees Up 29%

Guidance

Health Care

AngioDynamics Forecasts Fiscal Year 2025 Adjusted EPS Of $(0.38)-$(0.42), Compared To Fiscal 2024 Pro Forma Adjusted EPS Of $(0.45) Versus Consensus Of $(0.49)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sienna Biopharmaceuticals

News

Latest news for Sienna Biopharmaceuticals (OTC:SNNAQ) Stock

Thursday, February 27, 2020

Tuesday, January 21, 2020

Thursday, January 16, 2020